{"protocolSection":{"identificationModule":{"nctId":"NCT06168968","orgStudyIdInfo":{"id":"1941089"},"organization":{"fullName":"LifeBridge Health","class":"OTHER"},"briefTitle":"Multidisciplinary Approach to Reduce Cardiovascular Health Disparities","officialTitle":"Multidisciplinary Approach to Reduce Cardiovascular Health Disparities in the Baltimore RAcial Minority CommunitiEs (M-BRACE Trial)","acronym":"M-BRACE"},"statusModule":{"statusVerifiedDate":"2023-12","overallStatus":"RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2023-02-06","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2025-06","type":"ESTIMATED"},"completionDateStruct":{"date":"2025-08","type":"ESTIMATED"},"studyFirstSubmitDate":"2023-12-05","studyFirstSubmitQcDate":"2023-12-05","studyFirstPostDateStruct":{"date":"2023-12-13","type":"ACTUAL"},"lastUpdateSubmitDate":"2023-12-05","lastUpdatePostDateStruct":{"date":"2023-12-13","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"PRINCIPAL_INVESTIGATOR","investigatorFullName":"Paul A. Gurbel","investigatorTitle":"Director of Cardiovascular Research","investigatorAffiliation":"LifeBridge Health"},"leadSponsor":{"name":"LifeBridge Health","class":"OTHER"},"collaborators":[{"name":"University of Maryland","class":"OTHER"}]},"oversightModule":{"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"The goal of this observational study is to investigate the potential differences in thrombogenicity between black and white patients admitted with atherothrombotic events including acute coronary syndrome, multi-vessel coronary disease, and ischemic stroke.\n\nParticipants will engage in laboratory testing and health outcome assessments."},"conditionsModule":{"conditions":["Acute Coronary Syndrome","Multi Vessel Coronary Artery Disease","Ischemic Stroke"]},"designModule":{"studyType":"OBSERVATIONAL","patientRegistry":false,"designInfo":{"observationalModel":"COHORT","timePerspective":"PROSPECTIVE"},"enrollmentInfo":{"count":400,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"Cohort 1","description":"(Secondary Prevention) Includes black (n=150) and white (n=150) patients greater than or equal to 18 years of age hospitalized for acute coronary syndrome (ACS), multi-vessel disease, or ischemic stroke undergoing intervention","interventionNames":["Behavioral: Life and Medication Recommendations"]},{"label":"Cohort 2","description":"(Primary Prevention) Includes black subjects (n=75) who are first or second-degree relatives of patients in Cohort 1 and have no history of prior hospitalization for cardiovascular or cerebrovascular disease","interventionNames":["Behavioral: Life and Medication Recommendations"]}],"interventions":[{"type":"BEHAVIORAL","name":"Life and Medication Recommendations","description":"Based on obtained subjective and objective data from patient-filled questionnaire and laboratory testing respectively, lifestyle and medication recommendations will be provided for secondary prevention of cardiovascular and cerebrovascular diseases","armGroupLabels":["Cohort 1","Cohort 2"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Differences in Platelet Fibrin Clot Formation (MA,mm)","description":"Differences in Platelet Fibrin Clot Formation (MA,mm) Between Black and White Patients","timeFrame":"Baseline"},{"measure":"Differences in Speed of Clot Formation (R, min)","description":"Differences in Speed of Clot Formation (R, min) Between Black and White Patients","timeFrame":"Baseline"}],"secondaryOutcomes":[{"measure":"Major Adverse Cardiovascular Events Post Index Hospitalization","description":"Major Adverse Cardiovascular Events (death, MI, stroke, unplanned target vessel revascularization, major bleeding) Post Index Hospitalization","timeFrame":"3 and 12 months post index hospitalization"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patients â‰¥18 years of age admitted with ACS, AIS, or multi-vessel CAD\n* Competent mental condition to provide informed consent and able to participate in follow-ups\n\nExclusion Criteria:\n\n* Pregnant women\n* Currently enrolled in an investigational drug or device trial\n* Undergoing treatment for neoplastic, autoimmune, or connective tissue disease\n* COVID-19 infection within 30 days of enrollment\n* Known history of hepatitis or HIV\n* Deemed unfit to participate according to the investigator\n* Known history of drug abuse\n* Known platelet count of \\<100,000/mm3\n* Hematocrit \\< 25%","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"],"studyPopulation":"Two Cohorts (Cohort 1 = Secondary Prevention, Cohort 2 = Primary Prevention)\n\n- See information about specific Cohorts","samplingMethod":"NON_PROBABILITY_SAMPLE"},"contactsLocationsModule":{"centralContacts":[{"name":"Kevin Bliden, BS, MBA","role":"CONTACT","phone":"4432441497","email":"kbliden@lifebridgehealth.org"}],"overallOfficials":[{"name":"Jenna Brager, PhD","affiliation":"LifeBridge Health","role":"STUDY_CHAIR"}],"locations":[{"facility":"Sinai Hospital of Baltimore","status":"RECRUITING","city":"Baltimore","state":"Maryland","zip":"21215","country":"United States","contacts":[{"name":"Paul Gurbel, MD","role":"CONTACT","phone":"410-591-2473","email":"pgurbel@lifebridgehealth.org"},{"name":"Kevin Bliden, MBA","role":"CONTACT","phone":"443-244-1497","email":"kbliden@lifebridgehealth.org"},{"name":"Paul Gurbel, MD","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":39.29038,"lon":-76.61219}}]},"ipdSharingStatementModule":{"ipdSharing":"NO"}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000083242","term":"Ischemic Stroke"},{"id":"D000003324","term":"Coronary Artery Disease"},{"id":"D000054058","term":"Acute Coronary Syndrome"}],"ancestors":[{"id":"D000003327","term":"Coronary Disease"},{"id":"D000017202","term":"Myocardial Ischemia"},{"id":"D000006331","term":"Heart Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000001161","term":"Arteriosclerosis"},{"id":"D000001157","term":"Arterial Occlusive Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000020521","term":"Stroke"},{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","relevance":"LOW"},{"id":"M6236","name":"Coronary Artery Disease","asFound":"Coronary Artery Disease","relevance":"HIGH"},{"id":"M6239","name":"Coronary Disease","relevance":"LOW"},{"id":"M10233","name":"Ischemia","relevance":"LOW"},{"id":"M2401","name":"Ischemic Stroke","asFound":"Ischemic Stroke","relevance":"HIGH"},{"id":"M16045","name":"Syndrome","relevance":"LOW"},{"id":"M19196","name":"Myocardial Ischemia","relevance":"LOW"},{"id":"M27235","name":"Acute Coronary Syndrome","asFound":"Acute Coronary Syndrome","relevance":"HIGH"},{"id":"M9109","name":"Heart Diseases","relevance":"LOW"},{"id":"M4159","name":"Arteriosclerosis","relevance":"LOW"},{"id":"M4155","name":"Arterial Occlusive Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"T170","name":"Acute Graft Versus Host Disease","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"Rare","name":"Rare Diseases"}]}},"hasResults":false}